Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 2.71% | 170.48 | 0.7% | $1278.24m | |
| PFE | Pfizer Inc. | 0.07% | 37.31 | 0.9% | $1194.50m | |
| LLY | Eli Lilly & Co. | 0.31% | 213.00 | 1.1% | $1020.03m | |
| ABBV | AbbVie, Inc. | -1.53% | 108.81 | 1.9% | $749.27m | |
| AZN | AstraZeneca Plc | 0.80% | 54.44 | 1.2% | $709.95m | |
| MRK | Merck & Co., Inc. | -1.06% | 80.29 | 0.7% | $700.46m | |
| BMY | Bristol-Myers Squibb Co. | -0.60% | 64.44 | 1.0% | $698.52m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | -6.41% | 64.99 | 0.0% | $222.82m | |
| VTRS | Viatris, Inc. | -0.81% | 17.09 | 0.0% | $196.54m | |
| RPRX | Royalty Pharma Plc | 2.56% | 52.82 | 0.2% | $185.48m | |
| NVS | Novartis AG | -2.60% | 95.91 | 0.2% | $184.97m | |
| GSK | GlaxoSmithKline Plc | 0.82% | 39.24 | 0.2% | $163.38m | |
| GRTS | Gritstone Oncology, Inc. | -13.83% | 20.56 | 0.0% | $162.66m | |
| SNY | Sanofi | -0.97% | 49.15 | 0.2% | $137.60m | |
| TAK | Takeda Pharmaceutical Co., Ltd. | -0.98% | 18.19 | 0.0% | $80.46m |
Company Profile
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.